Master of Public Health - MPH / Background: Globally, it is estimated that about 1.8 million adolescents (aged 10–19 years) were living with HIV in 2015. In Kenya an estimated 133,455 adolescents were living with HIV in 2015, of which 75% (105,679) were in need of antiretroviral therapy (ART). Among adolescents on ART in 2016, 63% reported viral suppression; which is far below the UNAIDS targets of 90%. Viral suppression (having less than 1000 copies of viral RNA/ml of blood) is a key indicator of HIV treatment success, and is associated with better quality of life and reductions in HIV incidence at a population level. Homabay County recorded the highest HIV prevalence (26%) and the highest number of adolescents living with HIV in Kenya (15,323) in 2015. By the end of June 2017 5,709 adolescents were initiated on ART in Homabay County. Despite the successes in initiating HIV positive adolescents on ART, little is known about the factors that are associated with viral suppression. The current study investigated the factors associated with viral suppression among adolescents initiated on ART before November 30, 2017 in Homabay County, Kenya. Methods: A descriptive cross-sectional study was conducted among 925 adolescents registered on ART for at least 6 months and with at least one documented viral load in the last 12 months, in six health facilities in Homabay County. Data was extracted from the electronic medical records and exported into an excel spreadsheet. Bivariate and multivariate logistic regression analyses were conducted to identify factors associated to viral suppression using Stata 12.0.

Master of Public Health - MPH / Meningitis is a common opportunistic infection and an important cause of mortality among people living with HIV and AIDS globally. This study investigated meningitis in adults living with HIV and AIDS admitted to the medical wards of Livingstone tertiary hospital in Port Elizabeth in 2018 and determined the prevalence of its aetiological types, clinical presentations, diagnostic challenges, treatment outcomes and predictors of prognosis.

In this report, we describe a case of a 61-year-old male patient who had the bacterium growing in a blood culture. It was susceptible to ampicillin, ceftriaxone, levofloxacin, and vancomycin but was intermediately resistant to erythromycin. The patient did not have a negative outcome as a consequence of this bacterium, which retrospectively could have been predicted based on the epidemiological data within the patient's profile.

Blacks are more affected by Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) than any other race or ethnicity in the United States. The purpose of this dissertation was to investigate potential race-based differences in cardiovascular disease (CVD)-related hospitalizations and use of opportunistic infection (OI) prophylaxis between Blacks and Whites with HIV/AIDS. This dissertation includes two systematic literature reviews that identified knowledge gaps in the areas of CVD diagnosis and OI prophylaxis use between Blacks and Whites with HIV/AIDS, as well as two independent studies that addressed some of the gaps identified in the literature. The first study evaluated the association between race and CVD-related hospitalization in Blacks and Whites with HIV/AIDS. Data were retrieved from the 1996-2008 National Hospital Discharge Surveys (NHDS). Approximately 1.5 million hospital discharges were identified. After controlling for confounders, the odds of CVD-related hospitalization were 45% higher for Blacks than Whites (OR=1.45, 95% CI, 1.39-1.51). There was a statistically significant difference in the proportions of CVD-related hospitalization type and race (x2=479.77; df=3; p<0.001). Compared to Whites with HIV/AIDS, Blacks with HIV/AIDS had greater proportions of heart failure and hypertension, but lower proportions of stroke and coronary heart disease. These results suggest that there is an influence of race on both the occurrence and type of CVD-related hospitalizations in patients with HIV/AIDS. The second study assessed if race was associated with the use of OI prophylaxis (Pneumocystis jiroveci pneumonia [PCP] and Mycobacterium avium complex [MAC]). Data for this study were retrieved from the 1996-2008 National Hospital Ambulatory Medical Care Surveys (NHAMCS). Approximately 9.1 million hospital ambulatory visits were identified. After controlling for confounders, the odds of PCP prophylaxis use were 16% higher for Blacks than for Whites (OR=1.16, 95% CI, 1.15-1.17). In a separate regression analysis, the odds of MAC prophylaxis use were 12% higher for Blacks than for Whites (OR=1.12, 95% CI, 1.10-1.13). These findings suggest that Blacks with HIV/AIDS may have increased odds for OI prophylaxis. Based on this work, there is a need for further research to confirm these findings and to identify the causes of these race-based disparities. / text

Os resultados permitiram a redação de quatro artigos. Aspectos microbiológicos e clínicos de corinebacterioses em pacientes com câncer observados durante cinco anos foram descritos no Artigo 1. No Artigo 2 foram apresentados casos de bacteremia causados por corinebactérias invasivas não toxigênicas em dois períodos com intervalo de sete anos. As infecções em pacientes com câncer por C. diphtheriae, causando casos clínicos atípicos foram descritas no Artigo 3, além do estudo dos principais fatores de virulência de uma cepa de C. diphtheriae isolada de infecção associada ao cateter de nefrostomia foi descrita no Artigo 4. Resumidamente no Artigo 1, além dos aspectos clínico-epidemiológicos foram avaliados os perfis de resistência aos antimicrobianos e o potencial de virulência dos micro-organismos. Em cinco anos, 932 amostras de corinebactérias, com perfis de resistência aos antimicrobianos testados, foram isoladas de pacientes com câncer. As espécies predominantes foram Corynebacterium amycolatum (44,7%), Corynebacterium minutissimum (18,3%) e Corynebacterium pseudodiphtheriticum (8,5%). O uso de catéteres de longa permanência e a neutropenia, foram às condições importantes para infecção por corinebactérias. As doenças de base mais comuns foram os tumores sólidos. Pacientes hospitalizados apresentaram risco seis vezes maior de morrer, quando relacionadas às taxas de mortalidade com 30 dias (RC= 5,5; IC 95%= 1,15-26,30; p= 0,033). As bacteremias (Artigo 2) causadas por corinebactérias foram observadas em dois períodos: 2003-2004 (n=38) e de 2012-2013 (n=24). As espécies multirresistentes C. amycolatum e Corynebacterium jeikeium foram os principais responsáveis pelos quadros de bacteremia. Havia 34 pacientes com tumores sólidos e 28 pacientes com doenças linfoproliferativas, sendo que 21 deles apresentavam neutropenia e 54 utilizavam cateter venoso central. Em 41 pacientes havia infecção relacionada ou associada aos dispositivos intravasculares. Os pacientes com bacteremia responderam ao tratamento com vancomicina após a remoção do cateter. O comportamento agressivo da neoplasia, o tempo de internação hospitalar e o uso de CVC aumentaram o risco de bacteremias por Corynebacterium spp. No Artigo 3, 17 casos de infecções atípicas causadas por Corynebacterium diphtheriae foram diagnosticadas de 1996 a 2013. A incidência de C. diphtheriae correspondeu a 15,8 casos/100.000 admissões, 465 vezes maior que a incidência de difteria na população brasileira. Sintomas toxêmicos foram observados em nove pacientes, embora quadros de difteria clássica e endocardite não fossem observados. O perfil eletroforético em campo pulsado (PFGE) demonstrou um perfil de distribuição endêmica, apesar de haver dois casos de pacientes com o mesmo perfil eletroforético sugerindo transmissão relacionada aos cuidados à saúde. A adesão em superfícies bióticas e abióticas e produção de biofilme em cateter de poliuretano (Artigo 4) foi demonstrada em C. diphtheriae não toxigênico no sítio de inserção do cateter de nefrostomia. Os dados desses artigos permitiram concluir que (i) diferentes espécies de corinebactérias multirresistentes foram capazes de causar infecções em pacientes com câncer, incluindo bacteremias; (ii) C. diphtheriae foi capaz de causar infecções graves em indivíduos imunocomprometidos, incluindo infecções relacionadas ao uso de dispositivos invasivos em populações de risco, tais como pacientes com câncer. / A retrospective study at the InstitutoNacional doCâncer-INCA (National Cancer Institute) in Rio de Janeiro, Brazil examined infections of Corynebacterium sp. in cancer patients. The results were presented in four papers. Article 1 describes microbiological and clinical aspects of corynebacteriosis in cancer patients observed over five years. Article 2 presents cases of bacteremia caused by invasive non-toxigenic corynebacteria observed in 2003-2004 and seven years later in 2012-2013. Article 3 presents atypical clinical cases of cancer patients infected by Corynebacterium diphtheriae, while Article 4 is a study of the major bacterial virulence factors of an isolated strain of C. diphtheriae in infections associated with nephrostomy catheters.In addition to clinical and epidemiological aspects, Article 1 evaluates the antimicrobial resistance profiles and potential virulence factor of microorganisms. Over a period of five years, 932 samples of corynebacteria with antimicrobial resistance profiles were isolated from patients with cancer. The predominant species were Corynebacterium amycolatum (44.7%), Corynebacterium minutissimum (18.3%) and Corynebacterium pseudodiphtheriticum (8.5%).Long-term catheter use and neutropenia were the major conditions for infection by corynebacteria. Solid tumors were the most common underlying illness. The 30-day mortality rate for patients with corynebacteria infections was six times greater in hospitalized patients than for non-hospitalized patients (OR = 5.5, 95% CI = 1.15 to 26.30, p = 0.033).In Article 2, bacteremia caused by corynebacteria were observed in two time frames: 2003 to 2004 (n=38) and 2012 to 2103 (n=24). The multidrug-resistant species C. amycolatum and Corynebacterium jeikeium were responsible for invasive diseases.There were 34 patients with solid tumors and 28 patients with lymphoproliferative diseases, of which 21 had neutropenia and 54 used central venous catheter. Forty-one patients experienced infection related to or associated with intravascular device. Patients with bacteremia responded to treatment with vancomycin after removal of the catheter. The aggressive behavior of the neoplasia, the hospital stay and the use of central venous catheter increased risk of bacteremias by Corynebacterium sp. In Article 3, 17 cases of atypical infections caused by Corynebacterium diphtheriae were diagnosed from 1996 to 2013. The incidence of C. diphtheriae corresponded to 15.8 cases per 100,000 admissions which is 465 times greater than the incidence of diphtheria in the Brazilian population. Toxemic symptoms were observed in nine patients, although clinical signs of classical diphtheria and endocarditis were not observed.The Pulsed-field gel electrophoretic (PFGE) demonstrated a profile of endemic distribution, although there were two cases with identical profiles suggesting health care-related infections.Article 4demonstrates that non-toxigenic C. diphtheriae attaches to biotic and abiotic surfaces with the production of biofilm in polyurethane catheters at the nephrostomy insertion site. The data presented in these papers permit a conclusion the (i) different species of multidrug-resistant corynebacteria are capable of causing infections in cancer patients, including bacteremias; (ii) C. diphtheriae is capable of causing serious infections in immunocompromised individuals, including infections related to the use of disposable devices among at-risk populations such as those with cancer.

Os resultados permitiram a redação de quatro artigos. Aspectos microbiológicos e clínicos de corinebacterioses em pacientes com câncer observados durante cinco anos foram descritos no Artigo 1. No Artigo 2 foram apresentados casos de bacteremia causados por corinebactérias invasivas não toxigênicas em dois períodos com intervalo de sete anos. As infecções em pacientes com câncer por C. diphtheriae, causando casos clínicos atípicos foram descritas no Artigo 3, além do estudo dos principais fatores de virulência de uma cepa de C. diphtheriae isolada de infecção associada ao cateter de nefrostomia foi descrita no Artigo 4. Resumidamente no Artigo 1, além dos aspectos clínico-epidemiológicos foram avaliados os perfis de resistência aos antimicrobianos e o potencial de virulência dos micro-organismos. Em cinco anos, 932 amostras de corinebactérias, com perfis de resistência aos antimicrobianos testados, foram isoladas de pacientes com câncer. As espécies predominantes foram Corynebacterium amycolatum (44,7%), Corynebacterium minutissimum (18,3%) e Corynebacterium pseudodiphtheriticum (8,5%). O uso de catéteres de longa permanência e a neutropenia, foram às condições importantes para infecção por corinebactérias. As doenças de base mais comuns foram os tumores sólidos. Pacientes hospitalizados apresentaram risco seis vezes maior de morrer, quando relacionadas às taxas de mortalidade com 30 dias (RC= 5,5; IC 95%= 1,15-26,30; p= 0,033). As bacteremias (Artigo 2) causadas por corinebactérias foram observadas em dois períodos: 2003-2004 (n=38) e de 2012-2013 (n=24). As espécies multirresistentes C. amycolatum e Corynebacterium jeikeium foram os principais responsáveis pelos quadros de bacteremia. Havia 34 pacientes com tumores sólidos e 28 pacientes com doenças linfoproliferativas, sendo que 21 deles apresentavam neutropenia e 54 utilizavam cateter venoso central. Em 41 pacientes havia infecção relacionada ou associada aos dispositivos intravasculares. Os pacientes com bacteremia responderam ao tratamento com vancomicina após a remoção do cateter. O comportamento agressivo da neoplasia, o tempo de internação hospitalar e o uso de CVC aumentaram o risco de bacteremias por Corynebacterium spp. No Artigo 3, 17 casos de infecções atípicas causadas por Corynebacterium diphtheriae foram diagnosticadas de 1996 a 2013. A incidência de C. diphtheriae correspondeu a 15,8 casos/100.000 admissões, 465 vezes maior que a incidência de difteria na população brasileira. Sintomas toxêmicos foram observados em nove pacientes, embora quadros de difteria clássica e endocardite não fossem observados. O perfil eletroforético em campo pulsado (PFGE) demonstrou um perfil de distribuição endêmica, apesar de haver dois casos de pacientes com o mesmo perfil eletroforético sugerindo transmissão relacionada aos cuidados à saúde. A adesão em superfícies bióticas e abióticas e produção de biofilme em cateter de poliuretano (Artigo 4) foi demonstrada em C. diphtheriae não toxigênico no sítio de inserção do cateter de nefrostomia. Os dados desses artigos permitiram concluir que (i) diferentes espécies de corinebactérias multirresistentes foram capazes de causar infecções em pacientes com câncer, incluindo bacteremias; (ii) C. diphtheriae foi capaz de causar infecções graves em indivíduos imunocomprometidos, incluindo infecções relacionadas ao uso de dispositivos invasivos em populações de risco, tais como pacientes com câncer. / A retrospective study at the InstitutoNacional doCâncer-INCA (National Cancer Institute) in Rio de Janeiro, Brazil examined infections of Corynebacterium sp. in cancer patients. The results were presented in four papers. Article 1 describes microbiological and clinical aspects of corynebacteriosis in cancer patients observed over five years. Article 2 presents cases of bacteremia caused by invasive non-toxigenic corynebacteria observed in 2003-2004 and seven years later in 2012-2013. Article 3 presents atypical clinical cases of cancer patients infected by Corynebacterium diphtheriae, while Article 4 is a study of the major bacterial virulence factors of an isolated strain of C. diphtheriae in infections associated with nephrostomy catheters.In addition to clinical and epidemiological aspects, Article 1 evaluates the antimicrobial resistance profiles and potential virulence factor of microorganisms. Over a period of five years, 932 samples of corynebacteria with antimicrobial resistance profiles were isolated from patients with cancer. The predominant species were Corynebacterium amycolatum (44.7%), Corynebacterium minutissimum (18.3%) and Corynebacterium pseudodiphtheriticum (8.5%).Long-term catheter use and neutropenia were the major conditions for infection by corynebacteria. Solid tumors were the most common underlying illness. The 30-day mortality rate for patients with corynebacteria infections was six times greater in hospitalized patients than for non-hospitalized patients (OR = 5.5, 95% CI = 1.15 to 26.30, p = 0.033).In Article 2, bacteremia caused by corynebacteria were observed in two time frames: 2003 to 2004 (n=38) and 2012 to 2103 (n=24). The multidrug-resistant species C. amycolatum and Corynebacterium jeikeium were responsible for invasive diseases.There were 34 patients with solid tumors and 28 patients with lymphoproliferative diseases, of which 21 had neutropenia and 54 used central venous catheter. Forty-one patients experienced infection related to or associated with intravascular device. Patients with bacteremia responded to treatment with vancomycin after removal of the catheter. The aggressive behavior of the neoplasia, the hospital stay and the use of central venous catheter increased risk of bacteremias by Corynebacterium sp. In Article 3, 17 cases of atypical infections caused by Corynebacterium diphtheriae were diagnosed from 1996 to 2013. The incidence of C. diphtheriae corresponded to 15.8 cases per 100,000 admissions which is 465 times greater than the incidence of diphtheria in the Brazilian population. Toxemic symptoms were observed in nine patients, although clinical signs of classical diphtheria and endocarditis were not observed.The Pulsed-field gel electrophoretic (PFGE) demonstrated a profile of endemic distribution, although there were two cases with identical profiles suggesting health care-related infections.Article 4demonstrates that non-toxigenic C. diphtheriae attaches to biotic and abiotic surfaces with the production of biofilm in polyurethane catheters at the nephrostomy insertion site. The data presented in these papers permit a conclusion the (i) different species of multidrug-resistant corynebacteria are capable of causing infections in cancer patients, including bacteremias; (ii) C. diphtheriae is capable of causing serious infections in immunocompromised individuals, including infections related to the use of disposable devices among at-risk populations such as those with cancer.

The effects of HIV/AIDS and subsequent opportunistic infections and/or associated conditions on the development of infected children are substantial. Considerable delays and/or disorders in communication development have been noted in the HIV/AIDS infected child, as well as the need for Early Communication Intervention (ECI) services for this population. A dearth of locally relevant data regarding the speech, language and hearing development of HIV/AIDS infected children within the South African context currently exists. The objective of this study was to describe the characteristics of a group of HIV/AIDS infected children being managed at an outreach clinic of regional hospital in Gauteng. A cross-sectional, retrospective, non-experimental, descriptive, quantitative research design was used in this study. The main objective was achieved by analysing the clinic records of 203 children infected with HIV/AIDS between the ages of 0 – 5 years 11months through the use of a pre-designed checklist. A questionnaire completed by four medical doctors practicing at the HIV/AIDS clinic within the hospital was also used. This allowed for the perceptions and practices of the medical doctors to be described. Results revealed that the majority HIV/AIDS infected children being managed at the outreach clinic were significantly immunocompromised and diagnosed with Stage III or Stage IV HIV/AIDS infection. Furthermore, results indicated the presence of several opportunistic infections and HIV/AIDS associated conditions (such as Tuberculosis, Candidiasis and Encephalopathy). A positive finding was that 76% of the HIV/AIDS infected children (n=153) were receiving Highly Active Antiretroviral Therapy (HAART) at the time of data collection. The most outstanding finding was that very few of the children with HIV/AIDS being managed at the outreach clinic were recorded as having speech, language and/or hearing delays and/or disorders. Similarly, referrals to other professionals as recorded in the children’s hospital records seemed to be limited to Social Workers and Dietitians, with only one child recorded as being referred to a Speech-Language Therapist and Audiologist for further management. It was unclear whether more children were in fact referred for additional intervention by other professionals and this was simply not recorded in the children’s records, or whether these referrals were in fact not made. Results from the questionnaires completed by the medical doctors working with the pediatric HIV/AIDS population within the outreach clinic were significant. Findings indicated that the majority of the respondents believed that HIV/AIDS infected infants were more at risk for developmental and communicative delays and/or disorders than the general population, and that this population would likely benefit from Speech-Language Therapy and/or Audiology intervention services. Respondents indicated that medical doctors working with the pediatric HIV/AIDS population were often not adequately informed regarding the effects of HIV/AIDS on communication development and that they would benefit from further training in this regard. The need for further research regarding the characteristics of the pediatric HIV/AIDS population, particularly on a larger sample, was described. This would assist in the development of a guideline for ECI service delivery for children infected with HIV/AIDS. The need for further training of other professionals regarding the effects that HIV/AIDS has on the communication development of the infected child, to assist with necessary referrals and teamwork, was also highlighted. AFRIKAANS : Suid-Afrika is een van die lande ter wêreld, wat die hoogste voorkoms van Menslike Immuniteitsgebrekvirus/ Verworwe Immuniteitsgebreksindroom (MIV/VIGS), toon - met die pediatriese populasie op die voorfront van hierdie epidemie. Die effek wat MIV/VIGS en opeenvolgende opportunistiese infeksies en/of ander geassosieerde toestande op die ontwikkeling van kinders het, is verreikend. Internasionale literatuur beskryf agterstande en/of akwykings in die kommunikasie ontwikkeling van kinders wat met MIV/VIGS geinfekteer is. Die behoefte vir Vroeë Kommunikasie Intervensie (VKI) vir hierdie populasie word ook gemeld. Daar bestaan egter slegs ‘n beperkte hoeveelheid relevante, plaaslike literatuur met betrekking tot die spraak-, taal- en gehoorontwikkeling van kinders met MIV/VIGS binne die Suid-Afrikaanse konteks. Die doelwit van hierdie studie was om die kenmerke van ‘n groep kinders, wat met MIV/VIGS besmet is en by ‘n streekshospitaal in Gauteng behandel word, te beskryf. ‘n Kwantitatiewe, nie-eksperimentele, terugwerkende, dwarsdeurige, beskrywende navorsingsontwerp is gebruik. Die hoofdoelwit was bereik deur die kliniekrekords van kinders wat met MIV/VIGS besmet is, te analiseer deur van ‘n vooraf-ontwerpte merklys gebruik te maak. Data is ook ingesamel deur middel van vraelyste wat deur mediese dokters, wat by MIV/VIGS klinieke binne die hospitale werk, voltooi is. Dit het toegelaat dat die persepsies en praktyke van die mediese dokters ook beskryf kon word. Resultate het getoon dat die meerderheid kinders met MIV/VIGS, wat by klinieke behandel word, se immuunsisteme ernstig onderdruk was en dat hulle met stadium III of stadium IV van MIV/VIGS gediagnoseer was. Die resultate het verder ook die voorkoms van verskeie opportunistiese infeksies en MIV/VIGS geassosieerde toestande aangedui. ‘n Positiewe bevinding was dat 76% van die kinders (n=153), wat met MIV/VIGS geinfekteer was, tydens die proses van data-insameling reeds Hoogsaktiewe Antiretrovirale Terapie (HAART) ontvang het. Die mees uitstaande bevinding was dat slegs ‘n geringe hoeveelheid kinders met MIV/VIGS by die kliniek, as met ‘n agterstand en/of afwyking in spraak, taal en/of gehoor, aangeteken is. Beperkte verwysings na ander professionele persone is ook in die kliniekrekords opgemerk. Verwysings was beperk tot Maatskaplike Werkers en Dieëtkundiges. Daar was slegs een aantekening van ‘n kind wat vir behandeling na ‘n Spraak- en Taalterapeut en Oudioloog verwys is. Dit is egter onduidelik of daar werklik meer verwysings na ander professionele persone gemaak is, maar net nie in die kinders se kliniekrekords aangedui is nie, of dat daar werklik min verwysings na ander professionele dissiplines gemaak is. Bykomend, was die resultate van voltooide vraelyste deur mediese dokters, wat met die pediatriese MIV/VIGS populasie in die kliniek werk, insiggewend. Bevindings dui aan dat die meerderheid proefpersone, wat aan die studie deelgeneem het, van mening is dat kinders wat met MIV/VIGS besmet is wel ‘n hoër risiko toon vir ontwikkelings- en kommunikasie agterstande en/of afwykings in vergeleke met die algemene populasie. Die proefpersone is verder ook van mening dat hierdie populasie wel van spraak- en taalterapie en/of oudiologiese intervensie sal baatvind. Proefpersone het verder aangedui dat mediese dokters, wat met die pediatriese MIV/VIGS populasie werk, nie ten volle ingelig is omtrent die effek van MIV/VIGS op kommunikasie ontwikkeling en dat hulle van verdere opleiding sal baatvind. Die behoefte vir verdere navorsing in die veld van pediatriese MIV/VIGS en kommunikasie ontwikkeling, binne die Suid-Afrikaanse konteks, word in hierdie studie beskryf. Dit sal as riglyn vir VKI dienslewering aan hierdie populasie dien. Daar is ook ‘n groot behoefte vir verdere opleiding van ander mediese professionele persone met betrekking tot pediatriese MIV/VIGS en die effek wat die op die kind se kommunikasie ontwikkeling het. / Dissertation (MCommunication Pathology)--University of Pretoria, 2010. / Speech-Language Pathology and Audiology / unrestricted